Definitive Healthcare appoints Sastry Chilukuri to board; Randy Winn departs

Definitive Healthcare Corp.

Sastry Chilukuri, co-CEO of Medidata, joins board and audit committee effective Sept 30, 2022.
Randy Winn (22C Capital) steps down after serving since 2019; Chilukuri replaces him.
Chilukuri receives pro-rated annual retainer of $50k, initial RSU grant of 19,306 shares, and pro-rated annual RSU of 7,282 shares.
Chilukuri’s appointment aligns with expanding life sciences presence; he has 22+ years in healthcare technology.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

D. Randall Winn

Director

DH · Definitive Healthcare Corp.

Effective: 2022-09-30
Successor: Sastry Chilukuri
Filed: October 3, 2022, 7:59 PM ET

On September 29, 2022, D. Randall Winn resigned from the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”), which resignation became effective upon the appointment of Sastry Chilukuri as a member of the Board and of the audit committee of the Board (the “Audit Committee”) on September 30, 2022 (the “Effective Date”).

Appointed

Sastry Chilukuri

Director

DH · Definitive Healthcare Corp.

Effective: 2022-09-30
Filed: October 3, 2022, 7:59 PM ET

the appointment of Sastry Chilukuri as a member of the Board and of the audit committee of the Board (the “Audit Committee”) on September 30, 2022 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

D. Randall Winn resigned as Director at Definitive Healthcare Corp..

Action: resigned
Role: Director

Exact text from the filing

On September 29, 2022, D. Randall Winn resigned from the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”), which resignation became effective upon the appointment of Sastry Chilukuri as a member of the Board and of the audit committee of the Board (the “Audit Committee”) on September 30, 2022 (the “Effective Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Sastry Chilukuri was appointed as Director at Definitive Healthcare Corp..

Action: appointed
Role: Director

Exact text from the filing

the appointment of Sastry Chilukuri as a member of the Board and of the audit committee of the Board (the “Audit Committee”) on September 30, 2022 (the “Effective Date”).

View on SEC.gov

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0001193125-22-256657

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.